Charnock-Jones DS - Search Results

1

Antiangiogenic agents are effective inhibitors of endometriosis.

Hull ML, Charnock-Jones DS, Chan CL, Bruner-Tran KL, Osteen KG, Tom BD, Fan TP, Smith SK. Hull ML, et al. J Clin Endocrinol Metab. 2003 Jun;88(6):2889-99. doi: 10.1210/jc.2002-021912. J Clin Endocrinol Metab. 2003. PMID: 12788903

2

Soluble vascular endothelial growth factor receptor 1 inhibits edema and epithelial proliferation induced by 17beta-estradiol in the mouse uterus.

Hastings JM, Licence DR, Burton GJ, Charnock-Jones DS, Smith SK. Hastings JM, et al. Endocrinology. 2003 Jan;144(1):326-34. doi: 10.1210/en.2002-220641. Endocrinology. 2003. PMID: 12488361

3

Novel antiangiogenic agents for use in contraception.

Sharkey AM, Catalano R, Evans A, Charnock-Jones DS, Smith SK. Sharkey AM, et al. Contraception. 2005 Apr;71(4):263-71. doi: 10.1016/j.contraception.2004.12.018. Contraception. 2005. PMID: 15792645 Review.

4

Vascular endothelial growth factor expression in human endometrium is regulated by hypoxia.

Sharkey AM, Day K, McPherson A, Malik S, Licence D, Smith SK, Charnock-Jones DS. Sharkey AM, et al. J Clin Endocrinol Metab. 2000 Jan;85(1):402-9. doi: 10.1210/jcem.85.1.6229. J Clin Endocrinol Metab. 2000. PMID: 10634417 Clinical Trial.

5

Nimesulide, a COX-2 inhibitor, does not reduce lesion size or number in a nude mouse model of endometriosis.

Hull ML, Prentice A, Wang DY, Butt RP, Phillips SC, Smith SK, Charnock-Jones DS. Hull ML, et al. Hum Reprod. 2005 Feb;20(2):350-8. doi: 10.1093/humrep/deh611. Epub 2004 Nov 26. Hum Reprod. 2005. PMID: 15567877

6

Determination of the transcript profile of human endometrium.

Borthwick JM, Charnock-Jones DS, Tom BD, Hull ML, Teirney R, Phillips SC, Smith SK. Borthwick JM, et al. Mol Hum Reprod. 2003 Jan;9(1):19-33. doi: 10.1093/molehr/gag004. Mol Hum Reprod. 2003. PMID: 12529417

7

Wnt-1 signaling inhibits human umbilical vein endothelial cell proliferation and alters cell morphology.

Cheng CW, Smith SK, Charnock-Jones DS. Cheng CW, et al. Exp Cell Res. 2003 Dec 10;291(2):415-25. doi: 10.1016/j.yexcr.2003.07.006. Exp Cell Res. 2003. PMID: 14644163

8

Vascular development in embryoid bodies: quantification of transgenic intervention and antiangiogenic treatment.

Evans AL, Bryant J, Skepper J, Smith SK, Print CG, Charnock-Jones DS. Evans AL, et al. Angiogenesis. 2007;10(3):217-26. doi: 10.1007/s10456-007-9076-y. Epub 2007 Jun 19. Angiogenesis. 2007. PMID: 17577673

9

Transcript profile and localization of Wnt signaling-related molecules in human endometrium.

Cheng CW, Smith SK, Charnock-Jones DS. Cheng CW, et al. Fertil Steril. 2008 Jul;90(1):201-4. doi: 10.1016/j.fertnstert.2007.05.077. Epub 2007 Sep 24. Fertil Steril. 2008. PMID: 17889861 Free article.

10

Endometrial-peritoneal interactions during endometriotic lesion establishment.

Hull ML, Escareno CR, Godsland JM, Doig JR, Johnson CM, Phillips SC, Smith SK, Tavaré S, Print CG, Charnock-Jones DS. Hull ML, et al. Am J Pathol. 2008 Sep;173(3):700-15. doi: 10.2353/ajpath.2008.071128. Epub 2008 Aug 7. Am J Pathol. 2008. PMID: 18688027 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

202 results

Search Page